Literature DB >> 17221347

[Diagnosis of primary hyperaldosteronism].

Sven Diederich1, Martin Bidlingmaier, Marcus Quinkler, Martin Reincke.   

Abstract

Primary hyperaldosteronism is the most common secondary form of hypertension. Diagnosis of this entity is recommended in hypokalemic hypertension, in therapy-resistant hypertension (at least three 3 drugs and RR > 140/90 mmHg), and in adrenal incidentalomas (= incidentally discovered adrenal tumors). For screening, the ratio between plasma aldosterone (PAC) and plasma renin concentration (PRC) should be measured. In the assessment of PAC/PRC ratio, the discontinuation of some antihypertensive medication and assay-specific cutoff values must be noticed. After a positive screening test, saline infusion test should be done as confirmatory test. In contraindications/impracticability of this test, 24-h urine collection for aldosterone-18-glucuronide under high-sodium diet can be used as alternative confirmatory test. After confirmation of primary hyperaldosteronism, differential diagnosis between aldosterone-producing adenoma and idiopathic hyperaldosteronism has to be done. For this approach, adrenal CT or MRT, posture test and adrenal vein catheterization as gold standard test are available. Whereas therapy of aldosterone-producing adenoma is surgery, idiopathic hyperaldosteronism is to be treated medically by spironolactone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221347     DOI: 10.1007/s00063-007-1002-y

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  6 in total

1.  [Pareses, myalgias, and massive CK elevation: a severe neurological disorder?].

Authors:  Johannes Steinfurt; Markus C Müller; Anke Seidel; Richard Salm; Andreas Ochs
Journal:  Med Klin (Munich)       Date:  2010-07-30

2.  Predictors of malignancy in primary aldosteronism.

Authors:  Ayman Agha; Matthias Hornung; Igors Iesalnieks; Andreas Schreyer; Ernst Michael Jung; Assad Haneya; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

Review 3.  [Conn's syndrome].

Authors:  E Born-Frontsberg; M Quinkler
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

4.  The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.

Authors:  Caroline Schirpenbach; Felix Segmiller; Sven Diederich; Stefanie Hahner; Reinhard Lorenz; Lars C Rump; Jochen Seufert; Marcus Quinkler; Martin Bidlingmaier; Felix Beuschlein; Stephan Endres; Martin Reincke
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

5.  Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.

Authors:  Stefan Pilz; Andreas Tomaschitz; Vinzenz Stepan; Barbara Obermayer-Pietsch; Astrid Fahrleitner-Pammer; Natascha Schweighofer; Horst R Portugaller; Harald Sourij; Harald Dobnig; Andreas Meinitzer; Thomas R Pieber
Journal:  BMC Endocr Disord       Date:  2009-04-07       Impact factor: 2.763

6.  Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism.

Authors:  Stefan Pilz; Martin H Keppel; Christian Trummer; Verena Theiler-Schwetz; Marlene Pandis; Valentin Borzan; Matthias Pittrof; Barbara Obermayer-Pietsch; Martin R Grübler; Nicolas Verheyen; Vinzenz Stepan; Andreas Meinitzer; Jakob Voelkl; Winfried März; Andreas Tomaschitz
Journal:  J Endocr Soc       Date:  2019-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.